Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne

PHASE3CompletedINTERVENTIONAL
Enrollment

266

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

August 31, 2013

Conditions
Acne
Interventions
DRUG

Epiduo/Tactuo

topical to the face, once daily in the evening

OTHER

vehicle gel

topical to the face, once daily in the evening

DRUG

doxycycline 200mg

oral, 2 capsules once daily in the morning with aglass of water and with food

DRUG

Isotretinoin

oral, 0.5mg/kg/day for a period of four weeks, adjusted to 1 mg/kg/day for the four following months.

Trial Locations (25)

Unknown

Galderma investigational site, Ajax

Galderma investigational site, Barrie

Galderma investigational site, Calgary

Galderma investigational site, Edmonton

Galderma investigational site, Greater Sudbury

Galderma investigational site, Halifax

Galderma investigational site, Hamilton

Galderma investigational site, Markham

Galderma investigational site, Montreal

Galderma investigational site, Newmarket

Galderma investigational site, Oakville

Galderma investigational site, Oshawa

Galderma investigational site, Peterborough

Galderma investigational site, Québec

Galderma investigational site, Richmond Hill

Galderma investigational site, Saint-Hyacinthe

Galderma investigational site, Saskatoon

Galderma investigational site, St. John's

Galderma investigational site, Surrey

Galderma investigational site, Toronto

Galderma investigational site, Vancouver

Galderma investigational site, Waterloo

Galderma investigational site, Windsor

Galderma investigational site, Winnipeg

Galderma investigational site, Woodbridge

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY